Identifying Factors Influencing In-Hospital Relapse in Pemphigus Patients

This retrospective study conducted in China between January 2014 and December 2020 aimed to comprehensively examine factors influencing in-hospital relapse during acute episodes of pemphigus, an autoimmune blistering disease characterized by self-antibodies targeting desmogleins-essential cell adhesion molecules. The study enrolled 96 pemphigus patients who were hospitalized during acute episodes.

Research Questions:

Primary Question:

What are the identifiable risk factors associated with in-hospital relapse in pemphigus patients during acute episodes?

Methods:

Study Type: Retrospective Observational Study Participant Population: 96 pemphigus patients hospitalized in China Duration: January 2014 to December 2020

Main Tasks:

Data Collection:

Retrospective analysis of medical records and clinical data of pemphigus patients during acute hospitalizations.

Identification of demographic information, clinical characteristics, and treatment modalities.

Risk Factor Determination:

Univariate and multivariate Cox regression analysis employed to assess potential risk factors.

Variables considered included demographic factors, disease severity, and specific treatment regimens.

Outcome Measurement:

Identification of in-hospital relapse as the primary outcome. Correlation of relapse occurrence with the identified risk factors.

Results:

Key Findings:

Identification of specific risk factors contributing to in-hospital relapse in pemphigus patients.

Quantification of the impact of demographic and clinical variables on relapse probability.

Significance:

Clinical Implications:

Contribution of valuable insights for clinicians in predicting and managing in-hospital relapse in pemphigus patients.

Informing treatment strategies based on identified risk factors.

Research Contribution:

Expansion of understanding regarding the course and management of pemphigus. Providing a foundation for future prospective studies and the development of targeted interventions.

Inclusion criteria

• inpatients.
• Pathologic diagnosis of pemphigus.

Exclusion criteria

• Patients hospitalized for cyclophosphamide shock therapy only.
• Patients who did not recover and were discharged due to personal reasons.